What this study adds
- Resmetirom improves liver health, systemic dyslipidemia and liver
histopathology in diet-induced obese mice with biopsy-confirmed NASH
and fibrosis without causing weight loss
- Whole genome expression analysis indicates activation of the canonical
THR-β signaling pathway and down-regulation of genes involved in
fibrogenesis